Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo87
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond57
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer32
Natural and Engineered Cytokines as Cancer Therapeutics29
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy29
Immune Cell Metabolism and Immuno-Oncology29
Allogeneic CAR T Cell Therapy for Cancer26
Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer24
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity24
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division23
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?22
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology22
Road Map to Defeat Pancreatic Cancer21
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies19
Engineering Cancer with Next-Generation Genome Editing Tools19
Cancer Dependency Map: Past and Present19
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches18
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy17
0.028078079223633